Lifeward Ltd. (LFWD)
Nasdaq: LFWD · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Marlborough, MA · filing with the SEC since 2014
Who owns Lifeward Ltd.
As filed with the SECHolders of 5% or more
1
Oramed Pharmaceuticals Inc. holds 49.9% of Ordinary Shares, no par value, as its SCHEDULE 13D filed May 14, 2026 says.
Directors and officers
18
report now, of 37 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Oramed Pharmaceuticals Inc.
SCHEDULE 13D · filed May 14, 2026 · Ordinary Shares, no par value
Mitchell P. Kopin
SCHEDULE 13G · filed Jul 1, 2025 · Ordinary Shares, par value NIS 1.75 per share · reported falling below 5%, from 4.99% in Jan 14, 2025
Lind Global Fund II LP
SCHEDULE 13G/A · filed May 15, 2025 · Ordinary shares, par value NIS 1.75 · reported falling below 5%, from 8.9% in Jan 8, 2025
What LFWD reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Skelable Ltd
An entity · legal entity · owns, named in the 10-K filed Mar 18, 2026
3 subsidiaries in 2 countries, from the list filed with the 10-K filed Feb 27, 2024.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.